Koers Arch Therapeutics, Inc.
Aandelen
ARTH
US03939W2089
Medische apparatuur, benodigdheden & distributie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,18 USD | +3,51% | 0,00% | -83,70% |
Omzet 2022 | 0,02 0,01 | Omzet 2023 | 0,08 0,07 | Marktkapitalisatie | 6,1 mln. 5,69 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -5 mln. -4,67 mln. | Nettowinst (verlies) 2023 | -6 mln. -5,6 mln. | EV/omzet 2022 | 473.469.716 x |
Nettoschuld 2022 | 2,62 mln. 2,44 mln. | Nettoschuld 2023 | 5,41 mln. 5,05 mln. | EV/omzet 2023 | 151.885.320 x |
K/w-verhouding 2022 |
-0,87
x | K/w-verhouding 2023 |
-0,57
x | Werknemers | 8 |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 74,87% |
1 dag | +3,51% | ||
Lopende maand | -39,80% | ||
1 maand | -39,80% | ||
3 maanden | -67,13% | ||
6 maanden | +96,67% | ||
Lopend jaar | -83,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Michael Abrams
DFI | Director of Finance/CFO | 55 | 10-05-21 |
Shawn Carlson
SAM | Sales & Marketing | - | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Terrence Norchi
CEO | Chief Executive Officer | 59 | 16-09-09 |
Fish Guy
BRD | Director/Board Member | 64 | 31-12-21 |
Laurence Hicks
BRD | Director/Board Member | - | 27-09-21 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 1,18 | +3,51% | 618 |
23-04-24 | 1,14 | -3,39% | 316 |
uitgestelde koers OTC Markets, 24 april 2024 om 19:58 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
-83,70% | 5,24 mln. | |
+13,16% | 129 mld. | |
-9,23% | 10,77 mld. | |
+3,60% | 9,05 mld. | |
+19,75% | 7,38 mld. | |
+22,28% | 4,88 mld. | |
+7,55% | 3,41 mld. | |
-0,21% | 3,07 mld. | |
-4,80% | 2,24 mld. | |
-4,72% | 2,12 mld. |